Indications
Xoanacyl is indicated for the treatment of concomitant elevated serum phosphorous and iron deficiency in adult patients with chronic kidney disease (CKD).
Composition
- Active substance
- ferric citrate coordination complex
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Xoanacyl
- Active substance
- ferric citrate coordination complex
- ATC code
- V03AE08
- Group
- Various
- Therapeutic area
- Iron Deficiencies, Renal Insufficiency, Chronic, Hyperphosphatemia
- Marketing authorisation holder
- Averoa
- Status
- Authorised
- EU authorisation